
Keywords: aCL; anticardiolipin antibodies (aCL); Apl; anti-phospholipid antibodies; EDD; end-diastolic diameter; EF; ejection fraction; ESD; end-systolic diameter; FAC; Fractional Area shortening; FS; Fractional shortening; Hb; hemoglobin; IVS; interventricular sep